USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/3725
Title: Modificarea markerilor inflamaţiei la bolnavii cu bronhopneumopatie cronică obstructivă
Other Titles: The inflammatory markers modification in patients with chronic obstructive pulmonary disease
Authors: Butorov, Ivan
Ahmad Mahmoud, Chikh
Butorov, Valentina
Coşciuc, Irina
Antonova, Natalia
Issue Date: 2009
Publisher: CEP "Medicina"
Citation: BUTOROV, Ivan, AHMAD MAHMOUD, Chikh. et al. Modificarea markerilor inflamaţiei la bolnavii cu bronhopneumopatie cronică obstructivă . In: Anale Științifice ale USMF “Nicolae Testemiţanu”. Ed. a 10-a. Chișinău: CEP Medicina, 2009, vol. 3: Probleme actuale în medicina internă, pp. 192-196.
Abstract: The comparative efficiency of long term use of fenspirid and atrovent in 42 patients with chronic obstructive pulmonary disease was studied. It was noted that the 6 months administration of fenspirid contributed to a 2,6 times cough intensity decrease and atrovent – a 1,2 time decrease. The anti-inflammatory therapy had a positive effect on the level of proinflammatory cytokines that registered a 3 times decrease in patients that used fenspirid and 1,5 time decrease after atrovent. During the long term treatment with fenspirid VEF1 increased by 35,5% and by 21,2% - during the basic therapy. La 42 bolnavi cu bronhopneumapatie cronică obstructivă a fost studiată eficacitatea comparativă a tratamentului de durată cu fenspirid şi Atrovent. A fost stabilit că administrarea fenspiridului timp de 6 luni duce la micşorarea tusei de 2,6 ori, iar Atrovent – de 1,2 ori. Terapia antiinflamatorie a avut efect asupra citokinelor proinflamatoare, care s-au micşorat pe fon de tratament cu fenspirid de 3 ori, iar cu Atrovent de 1,5 ori. În rezultatul tratamentului de durată cu fenspirid VEMS a crescut cu 35,5%, iar pe fon de tratament de bază numai cu 21,2%.
URI: http://repository.usmf.md/handle/20.500.12710/3725
Appears in Collections:Ftiziopneumologie

Files in This Item:
File Description SizeFormat 
Modificarea_markerilor_inflamatiei_la_bolnavi.pdf225.82 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback